Filing Details
- Accession Number:
- 0001140361-16-068793
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-06-06 17:22:32
- Reporting Period:
- 2016-06-03
- Filing Date:
- 2016-06-06
- Accepted Time:
- 2016-06-06 17:22:32
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
943819 | Resmed Inc | RMD | Surgical & Medical Instruments & Apparatus (3841) | 980152841 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1196723 | David Pendarvis | Resmed Inc. 9001 Spectrum Center Blvd. San Diego CA 92123 | Chief Administrative Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Resmed Common Stock | Acquisiton | 2016-06-03 | 6,000 | $33.70 | 80,512 | No | 4 | M | Direct | |
Resmed Common Stock | Disposition | 2016-06-03 | 6,000 | $59.41 | 74,512 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Resmed Common Stock | ResMed Common Stock Options | Disposition | 2016-06-03 | 6,000 | $0.00 | 6,000 | $33.70 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
30,033 | 2011-11-11 | 2017-11-11 | No | 4 | M | Direct |
Footnotes
- The transaction was conducted under a Rule 10b5-1 plan.
- Represents date options first became exercisable. Options vest 1/4 per year.
- This transaction was executed in multiple trades at prices ranging from $59.31 to $59.57. The price reported above reflects the weighted average sale price.
- Includes 224.75 shares of ResMed stock purchased on May 5, 2016, through the ResMed Employee Stock Purchase Plan.